
OrganiGram Holdings OGI
€ 1.53
1.99%
Geschäftsbericht 2024
hinzugefügt 27.12.2025
OrganiGram Holdings EV/EBITDA 2011-2025 | OGI
EV/EBITDA Jährlich OrganiGram Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.79 | -3.06 | 72 | - | - | 36 | - | 35.1 | -111 | -1.25 K | -2.12 K |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 72 | -2.12 K | -418 |
EV/EBITDA anderer Aktien in der Arzneimittelhersteller
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
4.15 | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
-18.4 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
-4.28 | $ 1.21 | -7.63 % | $ 130 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-2.97 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.353 | - | 0.86 % | $ 117 M | ||
|
Cronos Group
CRON
|
-14.5 | $ 2.67 | -2.55 % | $ 1.44 B | ||
|
Catalent
CTLT
|
22.8 | - | - | $ 11.5 B | ||
|
Agile Therapeutics
AGRX
|
-18.5 | - | 10.11 % | $ 58.2 M | ||
|
DURECT Corporation
DRRX
|
1.47 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
160 | - | -39.89 % | $ 27.7 M | ||
|
Aurora Cannabis
ACB
|
-2.99 | $ 4.47 | -2.08 % | $ 86.3 M | ||
|
Endo International plc
ENDP
|
-1.77 | - | - | $ 28.9 M | ||
|
Zomedica Corp.
ZOM
|
8.79 | - | -0.21 % | $ 98 M | ||
|
Evoke Pharma
EVOK
|
-27.4 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-0.0195 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
-1.44 | - | 2.45 % | $ 38.1 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-0.574 | - | - | $ 55.5 M | ||
|
Emergent BioSolutions
EBS
|
7.77 | $ 12.36 | -2.37 % | $ 633 M | ||
|
Athenex
ATNX
|
-1.1 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-6.92 | $ 21.6 | 0.07 % | $ 2.06 B | ||
|
Evolus
EOLS
|
-9.74 | $ 6.88 | 0.36 % | $ 427 M | ||
|
Harrow Health
HROW
|
72.8 | $ 50.08 | -0.16 % | $ 1.63 B | ||
|
China Pharma Holdings
CPHI
|
51.8 | $ 1.29 | -1.56 % | $ 22.5 M | ||
|
Neoleukin Therapeutics
NLTX
|
0.202 | - | - | $ 193 M | ||
|
Bausch Health Companies
BHC
|
18.6 | $ 7.19 | -0.07 % | $ 2.62 B | ||
|
Lannett Company
LCI
|
-3.47 | - | 1.15 % | $ 7.11 M | ||
|
Organogenesis Holdings
ORGO
|
15.8 | $ 5.36 | -8.71 % | $ 706 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-19.4 | $ 4.11 | -2.14 % | $ 57.8 M | ||
|
Pacira BioSciences
PCRX
|
29.6 | $ 26.48 | 1.77 % | $ 1.22 B | ||
|
Sundial Growers
SNDL
|
-1.27 | $ 1.75 | -1.13 % | $ 3.37 M | ||
|
PetIQ
PETQ
|
9.82 | - | 1.64 % | $ 400 M | ||
|
Jupiter Wellness
JUPW
|
-50.5 | - | - | $ 33.6 M | ||
|
Perrigo Company plc
PRGO
|
11.2 | $ 13.87 | 0.95 % | $ 1.91 B | ||
|
ProPhase Labs
PRPH
|
9.86 | $ 0.51 | -16.94 % | $ 8.08 M | ||
|
Radius Health
RDUS
|
-13.2 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
13.4 | - | -4.76 % | $ 65.3 M | ||
|
Relmada Therapeutics
RLMD
|
-2.91 | $ 4.5 | -2.21 % | $ 135 M | ||
|
Rockwell Medical
RMTI
|
-13.7 | $ 0.87 | 7.18 % | $ 20.3 M | ||
|
OptiNose
OPTN
|
-2.04 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
7.11 | $ 9.92 | 0.22 % | $ 705 M | ||
|
PLx Pharma
PLXP
|
-1.81 | - | -27.8 % | $ 2.56 M | ||
|
Solid Biosciences
SLDB
|
-0.17 | $ 5.83 | -1.19 % | $ 238 M | ||
|
SCYNEXIS
SCYX
|
-1.32 | $ 0.58 | -1.87 % | $ 27.8 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
-4.16 | $ 3.63 | -0.41 % | $ 4.5 M | ||
|
Tricida
TCDA
|
-3.32 | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
-46 | $ 9.6 | -5.43 % | $ 5.93 B | ||
|
TherapeuticsMD
TXMD
|
-45.5 | $ 1.72 | 0.88 % | $ 18 M | ||
|
Veru
VERU
|
31.2 | $ 2.37 | 1.28 % | $ 320 M | ||
|
Viatris
VTRS
|
10.5 | $ 12.33 | 0.69 % | $ 14.9 B |